| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Interest Income | 7,966,829 | 5.973% | 7,517,775 | 7,223,583 | 7,495,134 | 6,949,999 |
| Interest Expense | (3,893,223) | -2.648% | (3,999,107) | (4,135,322) | (4,236,963) | (4,011,795) |
| Net Interest Income | 4,073,606 | 15.771% | 3,518,668 | 3,088,261 | 3,258,171 | 2,938,204 |
| Other Operating Income | 787,079 | -53.437% | 1,690,345 | 1,682,086 | 643,826 | 838,115 |
| Total Operating Income | 4,860,685 | -6.687% | 5,209,013 | 4,770,347 | 3,901,997 | 3,776,319 |
| Net Insurance Claims Incurred & Movement in Policyholders' Liabilities | 0 | -- | 0 | 0 | 0 | 0 |
| Net Operating Income | 4,860,685 | -6.687% | 5,209,013 | 4,770,347 | 3,901,997 | 3,776,319 |
| Operating Expenses | (2,064,194) | 15.041% | (1,794,319) | (1,722,652) | (1,575,183) | (1,507,790) |
| Impairment Losses on Loans & Advances | (847,709) | -29.856% | (1,208,526) | (1,546,190) | (904,751) | (1,098,822) |
| Other Impairment Losses | 132,982 | -- | (424,003) | (253,184) | (411,131) | (239,150) |
| Operating Profit / (Loss) | 2,081,764 | 16.811% | 1,782,165 | 1,248,321 | 1,010,932 | 930,557 |
| Change in FV & Impairment on Inv. Prop. | 0 | -- | 0 | 0 | 0 | 0 |
| Change in FV & Impairment on Others | 0 | -- | 0 | 0 | 0 | 0 |
| Profit / (Loss) on Disposal | 0 | -- | 0 | 0 | 0 | 0 |
| Other Non-operating Items | 0 | -- | 0 | 0 | 0 | 0 |
| Share of Results of Asso. & JCEs | 2,017 | -22.393% | 2,599 | 2,469 | 3,550 | 3,749 |
| Profit / (Loss) before Taxation | 2,083,781 | 16.754% | 1,784,764 | 1,250,790 | 1,014,482 | 934,306 |
| Taxation | (541,393) | 6.343% | (509,099) | (256,553) | (206,953) | (200,049) |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- |
| Non-controlling Interests | (962) | -- | 0 | 0 | 0 | 0 |
| Others | (111,900) | 17.666% | (95,100) | (95,100) | -- | -- |
| Profit / (Loss) Attributable to Shareholders | 1,429,526 | 21.088% | 1,180,565 | 899,137 | 807,529 | 734,257 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Depreciation & Amortisation | 202,177 | 13.059% | 178,824 | 167,300 | 175,763 | 180,806 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 53.000 | 23.256% | 43.000 | 33.000 | 26.000 | 24.000 |
| DPS (cts) | 13.000 | -- | 12.000 | 9.000 | 8.000 | 0.000 |
| Dividend Payout Ratio (%) | 24.528% | -- | 27.907% | 27.273% | 30.769% | -- |
| Cash flow per share ($) | (2.779) | -- | 0.629 | (3.254) | 0.638 | 0.174 |
| NBV per share ($) | 4.134 | -- | 3.732 | 3.396 | 3.127 | 2.946 |
| Remarks: | Real time quote last updated: 26/03/2026 13:15 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,429,526 |
| %Change | 21.088% |
| EPS / (LPS) | RMB 0.530 |
| NBV Per Share (¥) | RMB 4.134 |